Doctors test tailored treatments for Tough-to-Treat salivary gland cancer
NCT ID NCT05924256
Summary
This study is testing whether personalized drug treatments can help control advanced salivary gland cancer that has returned or spread. It will enroll 88 adults and assign them to one of four different drug regimens based on specific markers found in their tumor. The goal is to see if matching the treatment to the tumor's biology is more effective and safe than a one-size-fits-all approach.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SALIVARY GLAND CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dongmei Ji
Shanghai, China
Conditions
Explore the condition pages connected to this study.